Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses
Daniel Boakye1,2, Viola Walter1, Uwe M Martens3, Jenny Chang-Claude4, Michael Hoffmeister1, Lina Jansen1,*, Hermann Brenner1,5,6,* 1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; 2Medical Faculty Heidelberg, Heidelberg University, Hei...
Main Authors: | Boakye D, Walter V, Martens UM, Chang-Claude J, Hoffmeister M, Jansen L, Brenner H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-09-01
|
Series: | Clinical Epidemiology |
Subjects: | |
Online Access: | https://www.dovepress.com/treatment-selection-bias-for-chemotherapy-persists-in-colorectal-cance-peer-reviewed-article-CLEP |
Similar Items
-
Personalizing the Prediction of Colorectal Cancer Prognosis by Incorporating Comorbidities and Functional Status into Prognostic Nomograms
by: Daniel Boakye, et al.
Published: (2019-09-01) -
Comparison of long-term outcomes between Lynch sydrome and sporadic colorectal cancer: a propensity score matching analysis
by: Yun Xu, et al.
Published: (2021-01-01) -
Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
by: Bengt Glimelius, et al.
Published: (2020-08-01) -
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer
by: Gloria Chan, et al.
Published: (2020-11-01) -
Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer
by: Michelle C. M. Lee, et al.
Published: (2021-08-01)